• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas在生物工程、生物技术及转化研究中的应用

Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research.

作者信息

Lau Cia-Hin

机构信息

Department of Biomedical Engineering, City University of Hong Kong , Hong Kong, SAR, China .

出版信息

CRISPR J. 2018 Dec;1(6):379-404. doi: 10.1089/crispr.2018.0026.

DOI:10.1089/crispr.2018.0026
PMID:31021245
Abstract

CRISPR technology is rapidly evolving, and the scope of CRISPR applications is constantly expanding. CRISPR was originally employed for genome editing. Its application was then extended to epigenome editing, karyotype engineering, chromatin imaging, transcriptome, and metabolic pathway engineering. Now, CRISPR technology is being harnessed for genetic circuits engineering, cell signaling sensing, cellular events recording, lineage information reconstruction, gene drive, DNA genotyping, miRNA quantification, cloning, site-directed mutagenesis, genomic diversification, and proteomic analysis . It has also been implemented in the translational research of human diseases such as cancer immunotherapy, antiviral therapy, bacteriophage therapy, cancer diagnosis, pathogen screening, microbiota remodeling, stem-cell reprogramming, immunogenomic engineering, vaccine development, and antibody production. This review aims to summarize the key concepts of these CRISPR applications in order to capture the current state of play in this fast-moving field. The key mechanisms, strategies, and design principles for each technological advance are also highlighted.

摘要

CRISPR技术正在迅速发展,CRISPR应用的范围也在不断扩大。CRISPR最初用于基因组编辑。其应用随后扩展到表观基因组编辑、核型工程、染色质成像、转录组和代谢途径工程。现在,CRISPR技术正被用于基因回路工程、细胞信号传感、细胞事件记录、谱系信息重建、基因驱动、DNA基因分型、miRNA定量、克隆、定点诱变、基因组多样化和蛋白质组分析。它还已应用于人类疾病的转化研究,如癌症免疫治疗、抗病毒治疗、噬菌体治疗、癌症诊断、病原体筛查、微生物群重塑、干细胞重编程、免疫基因组工程、疫苗开发和抗体生产。本综述旨在总结这些CRISPR应用的关键概念,以把握这一快速发展领域的当前进展情况。还重点介绍了每项技术进展的关键机制、策略和设计原则。

相似文献

1
Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research.CRISPR-Cas在生物工程、生物技术及转化研究中的应用
CRISPR J. 2018 Dec;1(6):379-404. doi: 10.1089/crispr.2018.0026.
2
Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.通往系统生物技术未来之路:用于重组蛋白生产的CRISPR-Cas介导的代谢工程
Biotechnol Genet Eng Rev. 2016 Apr-Oct;32(1-2):74-91. doi: 10.1080/02648725.2016.1270095. Epub 2017 Jan 4.
3
The applications of CRISPR screen in functional genomics.CRISPR筛选在功能基因组学中的应用。
Brief Funct Genomics. 2017 Jan;16(1):34-37. doi: 10.1093/bfgp/elw020. Epub 2016 Jun 20.
4
Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.锌指蛋白、转录激活样效应因子及CRISPR系统:表观基因组编辑工具比较
Methods Mol Biol. 2018;1767:19-63. doi: 10.1007/978-1-4939-7774-1_2.
5
CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.CRISPR-cas 系统作为基因组工程平台:在生物医学和生物技术中的应用。
Curr Gene Ther. 2018;18(2):115-124. doi: 10.2174/1566523218666180221110627.
6
Genome Editing and Its Applications in Model Organisms.基因组编辑及其在模式生物中的应用。
Genomics Proteomics Bioinformatics. 2015 Dec;13(6):336-44. doi: 10.1016/j.gpb.2015.12.001. Epub 2016 Jan 4.
7
CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.CRISPR 工具在微生物基因组和表型工程中的应用
Biotechnol J. 2018 Sep;13(9):e1700586. doi: 10.1002/biot.201700586. Epub 2018 Jul 12.
8
The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.智能可编程 CRISPR 技术:研究人员的下一代基因组编辑工具。
Curr Drug Targets. 2017;18(14):1653-1663. doi: 10.2174/1389450117666160527142321.
9
CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges.CRISPR-Cas9疗法在癌症治疗中的应用:前景与挑战
Biochim Biophys Acta. 2016 Dec;1866(2):197-207. doi: 10.1016/j.bbcan.2016.09.002. Epub 2016 Sep 15.
10
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.CRISPR/Cas9与嵌合抗原受体T细胞(CAR-T细胞),癌症免疫治疗中两项革命性技术的协作,癌症成功治疗指南。
Hum Immunol. 2018 Dec;79(12):876-882. doi: 10.1016/j.humimm.2018.09.007. Epub 2018 Sep 24.

引用本文的文献

1
Design of lipid nanoparticle (LNP) containing genetic material CRISPR/Cas9 for familial hypercholesterolemia.用于家族性高胆固醇血症的含基因材料CRISPR/Cas9的脂质纳米颗粒(LNP)设计
Narra J. 2025 Apr;5(1):e2217. doi: 10.52225/narra.v5i1.2217. Epub 2025 Apr 15.
2
Efficient repair of human genetic defect by CRISPR/Cas9-mediated interlocus gene conversion.通过CRISPR/Cas9介导的基因座间基因转换实现人类遗传缺陷的高效修复。
Life Med. 2023 Nov 13;2(5):lnad042. doi: 10.1093/lifemedi/lnad042. eCollection 2023 Oct.
3
With a pinch of salt: metagenomic insights into Namib Desert salt pan microbial mats and halites reveal functionally adapted and competitive communities.
带着一点盐:对纳米布沙漠盐田微生物垫和盐晶的宏基因组学见解揭示了功能适应和竞争的群落。
Appl Environ Microbiol. 2023 Dec 21;89(12):e0062923. doi: 10.1128/aem.00629-23. Epub 2023 Nov 16.
4
Combined approaches for increasing fetal hemoglobin (HbF) and production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing.增加β地中海贫血患者红系细胞中胎儿血红蛋白(HbF)和成体血红蛋白(HbA)生成的联合方法:使用HbF诱导剂和基于CRISPR-Cas9的基因组编辑进行治疗
Front Genome Ed. 2023 Jul 17;5:1204536. doi: 10.3389/fgeed.2023.1204536. eCollection 2023.
5
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β39-Globin Gene Editing and Induction of Fetal Hemoglobin.用基于 CRISPR-Cas9 的β39 珠蛋白基因编辑与诱导胎儿血红蛋白对β-地中海贫血患者的红细胞进行共处理。
Genes (Basel). 2022 Sep 26;13(10):1727. doi: 10.3390/genes13101727.
6
PAM-flexible dual base editor-mediated random mutagenesis and self-activation strategies to improve CRISPRa potency.PAM灵活双碱基编辑器介导的随机诱变和自我激活策略以提高CRISPRa的效力。
Mol Ther Methods Clin Dev. 2022 May 29;26:26-37. doi: 10.1016/j.omtm.2022.05.005. eCollection 2022 Sep 8.
7
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β39-thalassemia patients.基于CRISPR-Cas9对纯合β39-地中海贫血患者红细胞系细胞中β-珠蛋白基因进行高效基因组编辑。
Mol Ther Methods Clin Dev. 2021 Apr 3;21:507-523. doi: 10.1016/j.omtm.2021.03.025. eCollection 2021 Jun 11.
8
CRISPR-based strategies for targeted transgene knock-in and gene correction.基于CRISPR的靶向转基因敲入和基因校正策略。
Fac Rev. 2020 Dec 4;9:20. doi: 10.12703/r/9-20. eCollection 2020.
9
A positive, growth-based PAM screen identifies noncanonical motifs recognized by the Cas9.基于生长的阳性PAM筛选可识别由Cas9识别的非经典基序。
Sci Adv. 2020 Jul 15;6(29):eabb4054. doi: 10.1126/sciadv.abb4054. eCollection 2020 Jul.